Possible recruitment of peripheral blood CXCR3+ CD27+ CD19+ B cells to the liver of chronic hepatitis C patients

Journal of Interferon and Cytokine Research

Volumn 30, Issue 4, 2010, Pages 243-251

  Mizuochi, Toshiaki ^a   Ito, Masahiko ^a   Saito, Koji ^b   Kasai, Michiyuki ^a   Kunimura, Toshiaki ^b   Morohoshi, Toshio ^b   Momose, Haruka ^a   Hamaguchi, Isao ^a   Takai, Kenji ^c   Iino, Shiro ^d   Suzuki, Miho ^e   Mochida, Satoshi ^f   Ikebuchi, Kenji ^e   Yamaguchi, Kazunari ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b SHOWA UNIVERSITY   (Japan)

^c SRL INC   (Japan)

^d Kiyokawa Hospital   (Japan)

^e Department of Transfusion and Cell Therapy ^*  (Japan)

^f SAITAMA MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD27 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; SCATTER FACTOR;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE MIGRATION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; MALE; MEMORY CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ADULT; AGED; ANTIGENS, CD19; ANTIGENS, CD27; B-LYMPHOCYTES; CASE-CONTROL STUDIES; CELL MOVEMENT; FEMALE; FLOW CYTOMETRY; HEPATITIS C, CHRONIC; HUMANS; LIGANDS; LIVER; MALE; MIDDLE AGED; RECEPTORS, CXCR3;

HEPATITIS C VIRUS;

EID: 77952495458     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2009.0047     Document Type: Article

References (25)

1. Agematsu K, Hokibara S, Nagumo H, Komiyama A. 2000. CD27: a memory B-cell marker. Immunol Today 21 (5):204-206.
2. Carbonari M, Caprini E, Tedesco T, Mazzetta F, Tocco V, Casato M, Russo G, Fiorilli M. 2005. Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: a model of infection-driven lymphomagenesis. J Immunol 174 (10):6532-6539.
3. Dammacco F, Sansonno D, Piccoli C, Racanelli V, D'Amore FP, Lauletta G. 2000. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy. Semin Liver Dis 20 (2):143-157.
4. Dore MP, Fattovich G, Sepulveda AR, Realdi G. 2007. Cryoglobulinemia related to hepatitis C virus infection. Dig Dis Sci 52 (4):897-907.
5. Galossi A, Guarisco R, Bellis L, Puoti C. 2007. Extrahepatic manifestations of chronic HCV infection. J Gastrointestin Liver Dis 16 (1):65-73.
6. Hansen A, Odendahl M, Reiter K, Jacobi AM, Feist E, Scholze J, Burmester GR, Lipsky PE, Dorner T. 2002. Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjogren's syndrome. Arthritis Rheum 46 (8):2160-2171.
7. Itoh Y, Morita A, Nishioji K, Narumi S, Toyama T, Daimon Y, Nakamura H, Kirishima T, Okanoue T. 2001. Clinical significance of elevated serum interferon-inducible protein-10 levels in hepatitis C virus carriers with persistently normal serum transaminase levels. J Viral Hepat 8 (5):341-348.
8. Lauer GM, Walker BD. 2001. Hepatitis C virus infection. N Engl J Med 345 (1):41-52.
9. Levy S, Todd SC, Maecker HT. 1998. CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol 16:89-109.
10. Machida K, Cheng KT, Lai CK, Jeng KS, Sung VM, Lai MM. 2006. Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation. J Virol 80 (14):7199-7207.
11. Machida K, Cheng KT, Pavio N, Sung VM, Lai MM. 2005. Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells. J Virol 79 (13):8079-8089.
12. Machida K, Cheng KT, Sung VM, Lee KJ, Levine AM, Lai MM. 2004. Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes. J Virol 78 (16):8835-8843.
13. Malbran A, Belmonte L, Ruibal-Ares B, Bare P, Massud I, Parodi C, Felippo M, Hodinka R, Haines K, Nichols KE, de Bracco MM. 2004. Loss of circulating CD27+ memory B cells and CCR4+ T cells occurring in association with elevated EBV loads in XLP patients surviving primary EBV infection. Blood 103 (5):1625-1631.
14. Manz RA, Moser K, Burmester GR, Radbruch A, Hiepe F. 2006. Immunological memory stabilizing autoreactivity. Curr Top Microbiol Immunol 305:241-257.
15. Muehlinghaus G, Cigliano L, Huehn S, Peddinghaus A, Leyendeckers H, Hauser AE, Hiepe F, Radbruch A, Arce S, Manz RA. 2005. Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells. Blood 105 (10):3965-3971.
16. Narumi S, Tominaga Y, Tamaru M, Shimai S, Okumura H, Nishioji K, Itoh Y, Okanoue T. 1997. Expression of IFN-inducible protein-10 in chronic hepatitis. J Immunol 158 (11):5536-5544.
17. Ni J, Hembrador E, Di Bisceglie AM, Jacobson IM, Talal AH, Butera D, Rice CM, Chambers TJ, Dustin LB. 2003. Accumulation of B lymphocytes with a naive, resting phenotype in a subset of hepatitis C patients. J Immunol 170 (6):3429-3439.
18. Ohno O, Mizokami M, Wu RR, Saleh MG, Ohba K, Orito E, Mukaide M, Williams R, Lau JY. 1997. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 35 (1):201-207.
19. Pal S, Sullivan DG, Kim S, Lai KK, Kae J, Cotler SJ, Carithers RL, Jr., Wood BL, Perkins JD, Gretch DR. 2006. Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism. Gastroenterology 130 (4):1107-1116.
20. Patzwahl R, Meier V, Ramadori G, Mihm S. 2001. Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppressionsubtractive hybridization. J Virol 75 (3):1332-1338.
21. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S. 1998. Binding of hepatitis C virus to CD81. Science 282 (5390):938-941.
22. Racanelli V, Frassanito MA, Leone P, Galiano M, De Re V, Silvestris F, Dammacco F. 2006. Antibody production and in vitro behavior of CD27-defined B-cell subsets: persistent hepatitis C virus infection changes the rules. J Virol 80 (8):3923-3934.
23. Rosa D, Saletti G, De Gregorio E, Zorat F, Comar C, D'Oro U, Nuti S, Houghton M, Barnaba V, Pozzato G, Abrignani S. 2005. Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc Natl Acad Sci USA 102 (51):18544-18549.
24. Vallat L, Benhamou Y, Gutierrez M, Ghillani P, Hercher C, Thibault V, Charlotte F, Piette JC, Poynard T, Merle-Beral H, Davi F, Cacoub P. 2004. Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection. Arthritis Rheum 50 (11):3668-3678.
25. Zignego AL, Giannini C, Ferri C. 2007. Hepatitis C virus-related lymphoproliferative disorders: an overview. World J Gastroenterol 13 (17):2467-2478.